Inventor · disambiguated record
Harald Althaus
Also filed as: ALTHAUS HARALD
19 granted patents·1 pending application·78 citations·filing 1992–2019
93Inventor score
Files withDADE BEHRING MARBURG GMBH7SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH6ALTHAUS HARALD2SIEMENS HEALTHCARE DIAGNOSTICS2BEHRINGWERKE AG1
Top patents by PatentIndex Score
20 records- 0188US7951910B2Peptides with the marburg I polymorphism of factor VII-activating protease (FSAP) and their preparation and usesSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2009·Granted May 31, 2011·11 cites·9 claims
- 0286US8932820B2Methods and kits for determining von Willebrand factor activity in the absence of ristocetin and for determining the activity of ADAMTS-13 proteaseALTHAUS HARALD·Filed 2012·Granted Jan 13, 2015·8 cites·12 claims
- 0385US6562946B2Human procalcitonin and the preparation and use thereofDADE BEHRING MARBURG GMBH·Filed 2000·Granted May 13, 2003·9 cites·27 claims
- 0484US9869683B2Methods and kits for determining von Willebrand factor activity in the absence of ristocetinSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH·Filed 2015·Granted Jan 16, 2018·2 cites·13 claims
- 0584US7338770B2Human procalcitonin and the preparation and use thereofDADE BEHRING MARBURG GMBH·Filed 2005·Granted Mar 4, 2008·5 cites·4 claims
- 0682US9222942B2Methods and kits for determining von willebrand factor activity in the absence of ristocetinALTHAUS HARALD·Filed 2010·Granted Dec 29, 2015·5 cites·27 claims
- 0777US6451311B2Anti-procalcitonin antibodies and the preparation and use thereofDADE BEHRING MARBURG GMBH·Filed 2000·Granted Sep 17, 2002·13 cites·11 claims
- 0865US10591490B2Methods and kits for determining von willebrand factor activity in the absence of ristocetinSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH·Filed 2017·Granted Mar 17, 2020·0 cites·20 claims
- 0957US6905687B2Human procalcitonin and the preparation and use thereofDADE BEHRING MARBURG GMBH·Filed 2003·Granted Jun 14, 2005·9 cites·16 claims
- 1056US9469687B2Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereofSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH·Filed 2015·Granted Oct 18, 2016·0 cites·7 claims
- 1156US7258989B2Carbohydrate deficient transferrin (CDT) -specific antibodies, their preparation and useDADE BEHRING MARBURG GMBH·Filed 2003·Granted Aug 21, 2007·1 cites·11 claims
- 1253US11320439B2Binding assay for the diagnosis of a heparin-induced thrombocytopeniaSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH·Filed 2018·Granted May 3, 2022·0 cites·12 claims
- 1352US11953503B2Method for quantitatively determining a therapeutic TNF-alpha inhibitorSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH·Filed 2019·Granted Apr 9, 2024·0 cites·9 claims
- 1451US11262357B2Activation assay for the diagnosis of a heparin-induced thrombocytopeniaSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH·Filed 2018·Granted Mar 1, 2022·0 cites·10 claims
- 1551US7622558B2Antibodies which are directed against the Marburg I polymorphism of factor VII-activating protease (FSAP), and their preparation and useSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2005·Granted Nov 24, 2009·3 cites·10 claims
- 1646US9453071B2Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereofVITZTHUM FRANK·Filed 2006·Granted Sep 27, 2016·0 cites·12 claims
- 1744US9096674B2Antibodies for determining the prothrombin fragment F2/F1+2 in a homogeneous immunoassayEHM MATTHIAS·Filed 2009·Granted Aug 4, 2015·0 cites·18 claims
- 1843US5258504AProcess for the purification of streptolysin O, intact streptolysin O obtainable by this processBEHRINGWERKE AG·Filed 1992·Granted Nov 2, 1993·8 cites·13 claims
- 1934US6440747B2Stabilization of biological fluids by addition of sterol estersDADE BEHRING MARBURG GMBH·Filed 1999·Granted Aug 27, 2002·4 cites·21 claims
- 2027US2003108550A1Anti-procalcitonin antibodies and the preparation and use thereofDADE BEHRING MARBURG GMBH·Filed 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →